Substrate

Bibliography

Biblio print

Tree Display

AceDB Schema

XML Display

Feedback

Substrate Report for: Methyl-2,5-dihydroxycinnamate

Tyrosine kinase inhibitor. Very potent cytotoxicity in a panel of human tumor cell lines but showed only marginal antitumor activity in mice due to the lability of the compound towards esterase hydrolysis in vivo


General
Type Aryl ester
Chemical_Nomenclature methyl (E)-3-(2,5-dihydroxyphenyl)prop-2-enoate
Canonical SMILES COC(=O)C=CC1=C(C=CC(=C1)O)O
InChI InChI=1S/C10H10O4/c1-14-10(13)5-2-7-6-8(11)3-4-9(7)12/h2-6,11-12H,1H3/b5-2+
InChIKey BQCNSTFWSKOWMA-GORDUTHDSA-N
Other name(s) Methyl 2,5-dihydroxycinnamate ; Erbstatin analog ; Methyl 3-(2,5-dihydroxyphenyl)acrylate ; 2,5-Dihydroxycinnamic acid methyl ester ; 2,4-Dihydroxymethylcinnamate
________________________________________________________________________________________________
MW|194.18
Formula|C10H10O4
CAS_number|63177-57-1
PubChem|5353609
UniChem|BQCNSTFWSKOWMA-GORDUTHDSA-N
IUPHAR|
Wikipedia|

Target

References:
Search PubMed for references concerning: Methyl-2,5-dihydroxycinnamate
    Title: Determinants and prediction of esterase substrate promiscuity patterns
    Martinez-Martinez M, Coscolin C, Santiago G, Chow J, Stogios PJ, Bargiela R, Gertler C, Navarro-Fernandez J, Bollinger A and Ferrer M <32 more author(s)>
    Ref: ACS Chemical Biology, 13:225, 2018 : PubMed

            

    Title: Synthesis and cytotoxicity of some rigid derivatives of methyl 2,5-dihydroxycinnamate
    Nam NH, Kim Y, You YJ, Hong DH, Kim HM, Ahn BZ
    Ref: Arch Pharm Res, 25:590, 2002 : PubMed